GO SPATIAL
LIVE

Serial Number

79388998

Owner

BGI SHENZHEN GROUP HOLDINGS CO., LIMITED

Attorney

Charles Ho

Filing Date

Jul 31, 2023

Add to watchlist:

No watchlists yet
View on USPTO

GO SPATIAL Trademark

Serial Number: 79388998 • Registration: 7781137

GO SPATIAL is a trademark filed by BGI SHENZHEN GROUP HOLDINGS CO., LIMITED on July 31, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BGI SHENZHEN GROUP HOLDINGS CO., LIMITED (9 trademarks)

8F, Building 11, Beishan Industrial

Entity Type: 99

Trademark Details

Filing Date

July 31, 2023

Registration Date

May 6, 2025

Published for Opposition

March 18, 2025

Goods & Services

Medical diagnostic reagents for the analysis of immune system; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; preparations for detecting mutation in prion genes for medical purposes; preparations for detecting genetic predispositions for medical purposes; reagent paper for medical purposes; reagents for use in medical genetic testing; biological preparations for medical purposes for the treatment of cancer and genetic diseases; chemical preparations being reagents for medical purposes; enzyme preparations for medical purposes

Apparatus for DNA and RNA testing for medical purposes; apparatus for blood analysis; apparatus used in implementing diagnosis tests designed to detect the abnormal prion protein; probes for medical purposes; medical diagnostic apparatus for detecting genetic diseases, infectious diseases, tumors and cancer; medical diagnostic apparatus for testing DNA and RNA samples; apparatus for use in medical analysis, namely, computerized medical recording and analysis apparatus for the diagnosis and analysis of cancer, genetic diseases and microbial infectious diseases; medical apparatus and instruments, namely, apparatus for detecting tumors, cancer and genetic diseases; medical apparatus and instruments, namely, apparatus for detecting and treating tumors and cancer; medical apparatus and instruments, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; testing apparatus for medical purposes, namely, blood testing apparatus, immunochemical testing apparatus; genetic testing apparatus for medical purposes; gas chromatography apparatus for medical use

Diagnostic reagents and preparations, except for medical or veterinary use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; biological preparations for use in cell cultures, other than for medical or veterinary purposes; biochemical preparations for scientific purposes; biological preparations, other than for medical or veterinary purposes, namely, biological preparations for use in industry and science; test paper, chemical; chemical preparations for scientific purposes, other than for medical or veterinary use; biological tissue cultures, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes

Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; stem cell therapy services; DNA screening for medical purposes; genetic testing for medical purposes; genetic screening for medical purposes; disease diagnosis services, namely, providing medical testing services for disease diagnosis, performing diagnosis of diseases; medical screening; telemedicine services; medical treatment using cultured cells; medical analysis for the diagnosis and treatment of patients; providing online information about medical services; genetic testing for medical purposes; medical consultations

Scientific laboratory services; biochemical research and analysis; medical research; research in the field of gene editing technology; research and development services in the field of antibodies; DNA screening for scientific research purposes; biological research; scientific research in the field of genetics; research on DNA sequencing technology; medical research in the field of oncology; pharmaceutical research and development; research in the field of DNA chip technology; genetic screening for scientific research purposes, namely, DNA screening for scientific research purposes; research in the field of cell engineering technology; structural and functional analysis of genomes; research and development services in the field of gene expression systems; genetic testing for scientific research purposes; medical research laboratories; software engineering services for data processing; computer programming in the medical field; computer programming; database development services

Data processing apparatus; recorded computer software for managing laboratory information, data, instruments and workflows in the field of genome sequencing; downloadable computer software for database management; recorded computer software for database management; laboratory equipment, namely, protein sequence analysis apparatus; testing apparatus not for medical purposes, namely, research laboratory analyzers for testing blood and other bodily fluids and electronic apparatus for testing the sterility of pharmaceuticals and injectable solutions; nucleic acid sequencers used for analyzing nucleic acids in scientific research; laboratory apparatus and instruments, namely, gene analyzers for genome information; DNA chips; laboratory devices for detecting genetic sequences; laboratory chemical reactors; pipette racks for laboratory use; laboratory instrument for the detection of pathogens and toxins in a biological sample for research use

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 18, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 27, 2025 FICS
FINAL DISPOSITION PROCESSED
Nov 26, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 6, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 26, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 7, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 7, 2025 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 6, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 6, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 12, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 24, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 29, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 29, 2024 TROA
REFUSAL PROCESSED BY IB
May 23, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 30, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 30, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 19, 2024 RFCR
NON-FINAL ACTION WRITTEN
Apr 18, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 30, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 16, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 9, 2024 REPR